We used a highly purified preparation of the naturally occurring core fragment of hCGβ (β-core) and a new RIA for β-core to investigate the concentrations and behavior of β-core in serum and urine. We collected serum and 24-h urine specimens from healthy pregnant women during the first trimester of pregnancy. The concentrations of β-core in serum were determined by analysis of fractions eluted from Sephadex G-100. Serum concentrations of β-core immunoreactivity were very low (0.13–1.25 μg/L), while large amounts of β-core were excreted in urine during pregnancy (as much as 4–5 mg/day). Interference with measurement by serum factors did not account for the low levels of β-core immunoreactivity in pregnancy serum. Based on the known urinary clearance rate of β-core in healthy nonpregnant subjects, we calculated that urinary clearance of serum β-core accounts for only about 1% of the β-core in pregnancy urine. We conclude that during pregnancy, the concentrations of β-core in plasma are measurable, but extremely low, and that most of the β-core in urine is derived by mechanisms other than urinary clearance of serum β-core; most likely, these mechanisms involve nephrogenous production of β- core from precursor molecules such as hCG and hCGβ.

This content is only available as a PDF.
You do not currently have access to this article.